Evaluation of Plasma Level of Anticoagulant Proteins (Protein C, S and Anti thrombin III) in Patients with Acute Lymphoblastic Leukemia | ||||
| Al-Azhar International Medical Journal | ||||
| Volume 2023, Issue 1, January 2023 | ||||
| DOI: 10.58675/2682-339X.1740 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| ibrahim Shehata Hazman1; Yousri Zaki Ali El Zoheri1; Mohamed Abdelhamid Khedr1; Osama Hassan Bakheet2 | ||||
| 1Department of Clinical Pathology, Faculty of Medicine, Al-Azhar University, Cairo | ||||
| 2Department of Clinical Pathology, Kobri El koba military Hospital | ||||
| Abstract | ||||
| Background: Acute lymphoblastic leukemia (ALL) is related to many coagulation abnormalities like hemorrhage & thrombosis. Objectives: research was to assess role of plasma activity levels of anticoagulant proteins in studied cases with acute lymphocytic leukemia. Patients and techniques: We researched thirty patients with confirmed ALL admitted in ELhussin or Said galal Hospital and twenty apparenty healthy as control group. Protein C, Protein S & Anti thrombin III are measured by coagulation analyzer (STAGO). Results: The mean activity levels of protein C (p=zero), Protein S (P=zero) & Anti thrombin III (p=zero) are highly significant lower in studied cases group compared to control group. Conclusion: The hypercoagulability state in ALL patients may attribute to the low level of protein C, protein S & Anti thrombin III. | ||||
|
Statistics Article View: 7 |
||||
